Work, Travel and Daily Life — on Trastuzumab
You have just been prescribed trastuzumab and you want to know what the next months will actually look like. For most people, daily life continues — with a three-weekly appointment built in.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Most people keep working — Trastuzumab alone does not cause the same fatigue as chemotherapy, and hair loss is not a typical side effect.
- Travel is possible — The three-week gap between infusions gives you a real window to travel, with some planning.
- Driving is not restricted — Trastuzumab does not affect alertness — most people drive throughout treatment.
- Social life is largely unchanged — Unlike chemotherapy, trastuzumab alone does not significantly lower your white cell count.
on Panel
Survival Rate*
Treated
(800+ reviews)
Most people on trastuzumab continue working, travelling, and managing daily life with few restrictions. The main thing to plan around is your infusion schedule — typically every three weeks — and regular heart monitoring. Trastuzumab alone does not suppress your immune system the way chemotherapy does.
Can you keep working during trastuzumab treatment?
Most people continue working throughout trastuzumab. The drug targets the HER2 protein on cancer cells, which means it does not cause the broad cell damage that makes chemotherapy so tiring — hair loss is also not a common side effect of trastuzumab on its own.
You will need time for each infusion appointment. Once the first doses are established, the infusions are shorter, and many people schedule them in the morning and return to work the same afternoon.
If you are receiving trastuzumab alongside chemotherapy, the chemotherapy side effects — not the trastuzumab — are more likely to affect your energy and attendance. Ask your team to be specific about which part of your regimen is likely to affect you most.
Can you travel while having trastuzumab?
Travel between infusions is possible for most people. The three-week interval gives you a genuine window, and the infusion itself does not typically leave you unwell for days afterwards.
The main constraint is timing. If a travel date clashes with an infusion, ask your oncologist in advance — doses can sometimes be moved by a few days, but this needs to be planned rather than assumed.
Inform your travel insurer that you are on active cancer treatment before you buy the policy, not after a problem arises. Carry a signed letter from your oncologist with your diagnosis, the name of your treatment, and your centre's contact details.
How to plan travel around your infusion schedule
Check your infusion dates first
Find out the dates of your next three or four infusions before you book anything. Your treatment centre can print this for you.
Ask whether a dose can shift
If a travel date clashes, ask your oncologist early — the further in advance you ask, the more options they have for rescheduling. Never delay a dose without asking first.
Check your heart-monitoring schedule
Trastuzumab requires regular echocardiograms. If one falls while you are away, ask whether it can be done at another accredited centre near where you will be staying.
Get a treatment letter
Ask your oncologist for a signed letter with your diagnosis, treatment name, and centre contact details. Keep it in your hand luggage, not your checked bag.
Tell your insurer before you leave
Declare your treatment to your travel insurer before purchasing the policy or travelling. Disclosing after an incident occurs is too late for cover to apply.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
Can you drive and socialise normally on trastuzumab?
Trastuzumab does not affect alertness or coordination, and driving is not restricted. Most people drive throughout their treatment without any change to their usual routine.
On your first few infusion days, it is sensible to arrange a lift home until you know how your body responds. Infusion reactions, when they happen, tend to occur during or shortly after the drip rather than hours later — but caution at the start is reasonable.
Social activities are not restricted in the same way as during chemotherapy. Trastuzumab alone does not significantly lower your white cell count, so crowded places are not the same concern. If your regimen includes chemotherapy alongside trastuzumab, ask your team what the right precautions are for your specific treatment.
What to have ready on infusion days
- Your hospital card and a photo identity document
- A written list of all medicines, supplements and herbal preparations you are taking
- A snack and a water bottle
- Something to read, listen to, or watch — infusions take time once set up
- Loose or easy-access clothing for the arm or port site
- The unit's contact number in case you are running late or feel unwell on the way
Did you know?
Because trastuzumab targets the HER2 protein specifically, it does not damage bone marrow the way chemotherapy does.
NCCN guidance notes that the infection-prevention precautions required during myelosuppressive chemotherapy do not apply to trastuzumab alone — which is why most people can continue social activities, eating out, and travel without the same restrictions.
Source: NCCN Clinical Practice Guidelines in Oncology — Breast Cancer
Explore 75 more Breast Cancer Targeted Medicines topics
Drug Deep Dive: Trastuzumab (Herceptin)
- Adjuvant Trastuzumab: Why Exactly 12 Months After Surgery?
- Diet and Nutrition While on Trastuzumab
- Drug, Food and Supplement Interactions With Trastuzumab
- Fatigue, Chills and Flu-Like Symptoms After a Trastuzumab Infusion
- Fertility, Pregnancy and Contraception on Trastuzumab
- Heart Function and Trastuzumab: Understanding Your ECHO Reports
- Herceptin vs Biosimilar Trastuzumab: Are They Really the Same?
- How Does Trastuzumab Work? The Anti-HER2 Monoclonal Antibody Explained
- How Long Does Trastuzumab Take to Work?
- How Long Will You Stay on Trastuzumab?
- Subcutaneous Trastuzumab vs IV Infusion: Which Suits You Better?
- Tests and Monitoring While You Are on Trastuzumab
- Trastuzumab (Herceptin and biosimilars): The Complete Patient Guide
- Trastuzumab Infusion Day: Premedication, Duration and What to Expect
- Trastuzumab Infusion Reactions: What Happens and How They're Managed
- Trastuzumab Myths: 'It's Chemotherapy' and Other Misunderstandings
- Trastuzumab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Trastuzumab Side Effects: The Complete List and Timeline
- Trastuzumab Success Rate and Survival: An Honest Look at the Numbers
- Trastuzumab With Pertuzumab, Chemotherapy and Hormone Therapy
- Trastuzumab in Elderly Patients and Those With Other Illnesses
- When Trastuzumab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Trastuzumab? HER2-Positive Breast and Gastric Cancer
- Will Insurance or a Government Scheme Pay for Trastuzumab?
- Work, Travel and Daily Life on Trastuzumab
Drug Deep Dive: Palbociclib (Ibrance)
- Diet and Nutrition While on Palbociclib
- Drug, Food and Supplement Interactions With Palbociclib
- Fatigue on Palbociclib: Why It Happens and What Genuinely Helps
- Fertility, Pregnancy and Contraception on Palbociclib
- How Does Palbociclib Work? The CDK4/6 Inhibitor Explained
- How Long Does Palbociclib Take to Work?
- How Long Will You Stay on Palbociclib?
- Low White Cell Count on Palbociclib: Expected, and Rarely Dangerous
- Mouth Sores and Infection Risk on Palbociclib
- Palbociclib (Ibrance, Palbace): The Complete Patient Guide
- Palbociclib Myths: Low Counts, Hair Loss and Stopping Early
- Palbociclib Price in India: Brand, Generic and Monthly Cost
- Palbociclib Side Effects: The Complete List and Timeline
- Palbociclib Success Rate and Survival: An Honest Look at the Numbers
- Palbociclib With Letrozole or Fulvestrant: Understanding Your Combination
- Palbociclib in Early Breast Cancer: Why It Is Not Given After Surgery
- Palbociclib in Elderly Patients and Those With Other Illnesses
- Palbociclib vs Ribociclib vs Abemaciclib: Which CDK4/6 Inhibitor?
- Taking Palbociclib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Palbociclib
- The 21-Days-On, 7-Days-Off Palbociclib Cycle Explained
- When Palbociclib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Palbociclib? Hormone-Receptor-Positive, HER2-Negative Breast Cancer
- Will Insurance or a Government Scheme Pay for Palbociclib?
- Work, Travel and Daily Life on Palbociclib
Drug Deep Dive: Trastuzumab Deruxtecan (Enhertu)
- Diet and Nutrition While on Trastuzumab Deruxtecan
- Drug, Food and Supplement Interactions With Trastuzumab Deruxtecan
- Enhertu Myths: 'It's Just Stronger Herceptin' and Cost Misconceptions
- Enhertu in Breast, Gastric and Lung Cancer: One Drug, Three Diseases
- Fertility, Pregnancy and Contraception on Trastuzumab Deruxtecan
- HER2-Low Breast Cancer: How Enhertu Created an Entirely New Patient Group
- How Does Trastuzumab Deruxtecan Work? The HER2-Directed Antibody-Drug Conjugate Explained
- How Long Does Trastuzumab Deruxtecan Take to Work?
- How Long Will You Stay on Trastuzumab Deruxtecan?
- Interstitial Lung Disease on Enhertu: The Side Effect That Needs Immediate Action
- Low Blood Counts, Hair Loss and Heart Monitoring on Enhertu
- Nausea and Vomiting on Trastuzumab Deruxtecan: Managing a High-Risk ADC
- Tests and Monitoring While You Are on Trastuzumab Deruxtecan
- Trastuzumab Deruxtecan (Enhertu): The Complete Patient Guide
- Trastuzumab Deruxtecan Infusion Day: Premedication, Duration and What to Expect
- Trastuzumab Deruxtecan Price in India: Innovator, Biosimilar and Cost Per Cycle
- Trastuzumab Deruxtecan Side Effects: The Complete List and Timeline
- Trastuzumab Deruxtecan Success Rate and Survival: An Honest Look at the Numbers
- Trastuzumab Deruxtecan in Elderly Patients and Those With Other Illnesses
- Trastuzumab Deruxtecan vs T-DM1 and Trastuzumab: How ADCs Differ
- When Trastuzumab Deruxtecan Stops Working: Resistance and What Comes Next
- Where Trastuzumab Deruxtecan Fits Alongside Chemotherapy and Hormone Therapy
- Who Is Eligible for Trastuzumab Deruxtecan? HER2-Positive and HER2-Low Breast, Gastric and Lung Cancer
- Will Insurance or a Government Scheme Pay for Trastuzumab Deruxtecan?
- Work, Travel and Daily Life on Trastuzumab Deruxtecan
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Frequently asked questions
Can I drink alcohol during trastuzumab treatment?
There is no direct prohibition on alcohol from NCCN or ASCO guidance for trastuzumab alone. The more relevant question is whether you are receiving other drugs alongside it — some chemotherapy agents and supportive medicines interact with alcohol — and whether your liver or heart function is being monitored as part of your treatment. Tell your oncologist what you drink so they can advise based on your full regimen, rather than applying a general rule that may not fit your situation.
Do I need to tell my employer I am on trastuzumab?
You are not required to disclose your diagnosis or treatment name to your employer. Most people on trastuzumab continue working without sharing those details. If you need flexibility for infusion days, it is often enough to say you have a medical appointment every three weeks, without naming the drug or the condition. Whether to say more is a personal decision based on your workplace and what support you may need.
What if I miss an infusion because of travel or illness?
Contact your treatment centre as soon as you know there is a problem — do not skip a dose and resume the following cycle without telling anyone. The sooner you flag a scheduling conflict, the more options your team has for rescheduling. Your oncologist will advise on timing based on where you are in your treatment plan and how much flexibility exists. Missing doses without discussion is what creates the real problem.
Can I exercise during trastuzumab treatment?
Exercise is generally encouraged. ASCO and ESMO guidelines support staying physically active during cancer treatment where possible, because it helps with fatigue, mood and cardiovascular fitness. The specific guidance for you depends on whether your heart monitoring has shown any changes — trastuzumab requires regular echocardiograms precisely because cardiac function is monitored — and whether your regimen includes other treatments that affect your stamina. Ask your oncologist before starting a new or intensive programme.
What symptoms between infusions should I call about?
Mild fatigue, an occasional headache, or a loose stool that settles within a day can wait until your next appointment if they are not worsening. Symptoms that need a same-day call include chest pain, unusual breathlessness, significant leg swelling, a fever, or anything that is getting worse rather than stable. Your treatment centre should give you a contact for between-infusion concerns — if you are unsure whether a symptom warrants a call, the safe answer is to call.